This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Other. Active years: 2011.
Company Filing History:
1 out of 834,307 Years Active: 2011
Title: Joseph Abecassis: Innovator in Cancer Diagnostics
Introduction
Joseph Abecassis is a notable inventor based in Strasbourg, France. He has made significant contributions to the field of cancer diagnostics, particularly in the study of squamous cell carcinoma. His work focuses on the expression of CTIP2, a protein that plays a crucial role in the diagnosis and staging of this type of cancer.
Latest Patents
Abecassis holds a patent for his invention titled "CTIP2 expression in squamous cell carcinoma." This patent provides methods for diagnosing and staging squamous cell carcinomas, such as head and neck squamous cell carcinoma (HNSCC), by detecting the expression of chicken ovalbumin upstream promoter-transcription factor-interacting protein 2 (CTIP2). The findings demonstrate that CTIP2 expression is significantly increased in SCC compared to normal samples. Additionally, the patent includes kits for detecting SCC and methods for identifying CTIP2 inhibitors.
Career Highlights
Throughout his career, Joseph Abecassis has worked with esteemed institutions, including the Centre National de La Recherche Scientifique. His research has contributed to advancements in cancer diagnostics, enhancing the understanding of squamous cell carcinoma and its treatment options.
Collaborations
Abecassis has collaborated with notable colleagues, including Arup Kumar Indra and Gitali Indra. Their joint efforts have furthered research in the field and contributed to the development of innovative diagnostic methods.
Conclusion
Joseph Abecassis is a pioneering inventor whose work in cancer diagnostics has the potential to improve patient outcomes. His patent on CTIP2 expression in squamous cell carcinoma represents a significant advancement in the field.